Blue Trust Inc. Raises Stock Position in The Cigna Group (NYSE:CI)

Blue Trust Inc. lifted its stake in shares of The Cigna Group (NYSE:CI) by 43.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,510 shares of the health services provider’s stock after acquiring an additional 1,069 shares during the quarter. Blue Trust Inc.’s holdings in The Cigna Group were worth $969,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. ORG Wealth Partners LLC purchased a new position in shares of The Cigna Group during the fourth quarter worth approximately $34,000. Ulland Investment Advisors LLC boosted its stake in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Prospera Private Wealth LLC bought a new position in shares of The Cigna Group during the third quarter valued at approximately $37,000. Harbor Capital Advisors Inc. bought a new position in shares of The Cigna Group during the third quarter valued at approximately $45,000. Finally, Intact Investment Management Inc. bought a new position in shares of The Cigna Group during the third quarter valued at approximately $69,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have weighed in on CI. Deutsche Bank Aktiengesellschaft lowered their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Royal Bank of Canada decreased their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Barclays raised their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $395.93.

The Cigna Group Stock Down 1.0 %

CI opened at $302.74 on Wednesday. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The company has a fifty day moving average of $296.85 and a two-hundred day moving average of $325.37. The stock has a market capitalization of $84.21 billion, a price-to-earnings ratio of 28.56, a PEG ratio of 0.78 and a beta of 0.54.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The business had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. During the same quarter last year, the business earned $6.77 earnings per share. The company’s revenue for the quarter was up 29.8% compared to the same quarter last year. On average, research analysts expect that The Cigna Group will post 28.5 earnings per share for the current year.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.